Literature DB >> 16848131

Physician factors as an indicator of technological device adoption.

LaToya C Artis1, Theresa M Burkhart, Tricia J Johnson, Karl A Matuszewski.   

Abstract

This paper analyzes a sample interventional cardiologist's demographic, academic, and professional characteristics to provide an understanding of their technological device adoption styles. The study sample consisted of 15 physicians from two large Midwestern hospitals, one an academic medical center and the other a medium-sized community hospital. Interventional cardiologists were identified through their online physician profile and respective departments. A questionnaire was developed to assess each physician's self-perceived adoption style, their awareness of the new technology, their participation in clinical trials, organizational support, and how various factors influence their adoption of new technology. Lastly, a database of bare metal and drug eluting stents was examined to document the number of stents used by each physician. Pragmatic and observational findings are presented from the questionnaire, physician profile, to database on stent use. The paper concludes with a discussion of the managerial and forecasting implications and methods to promote technology adoption.

Entities:  

Mesh:

Year:  2006        PMID: 16848131     DOI: 10.1007/s10916-005-8066-2

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.920


  15 in total

1.  Drug eluting stents: maximising benefit and minimising cost.

Authors:  J Gunn; A C Morton; C Wales; C M H Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

2.  Could your financial health be heading for heart break?

Authors:  Hugo J Finarelli
Journal:  Healthc Financ Manage       Date:  2003-08

3.  Drug-eluting stents: the new gold standard for percutaneous coronary revascularisation.

Authors:  Antonio Colombo; Ioannis Iakovou
Journal:  Eur Heart J       Date:  2004-06       Impact factor: 29.983

4.  Externalities in hospitals and physician adoption of a new surgical technology: an exploratory analysis.

Authors:  J J Escarce
Journal:  J Health Econ       Date:  1996-12       Impact factor: 3.883

5.  Turf battles in coronary revascularization.

Authors:  Robert S Huckman; Gary P Pisano
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

Review 6.  Defining coronary restenosis. Newer clinical and angiographic paradigms.

Authors:  R E Kuntz; D S Baim
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

7.  Prostate-specific antigen for prostate cancer screening. Do physician characteristics affect its use?

Authors:  K L Edlefsen; M T Mandelson; M W McIntosh; M R Andersen; E H Wagner; N Urban
Journal:  Am J Prev Med       Date:  1999-07       Impact factor: 5.043

Review 8.  Drug-coated stents: preventing restenosis in coronary artery disease.

Authors:  Julie A Stanik-Hutt
Journal:  J Cardiovasc Nurs       Date:  2004 Nov-Dec       Impact factor: 2.083

Review 9.  Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease.

Authors:  Paul P Dobesh; Zachary A Stacy; Alexander J Ansara; Jason M Enders
Journal:  Pharmacotherapy       Date:  2004-11       Impact factor: 4.705

Review 10.  Drug-eluting stents: new era and new concerns.

Authors:  V Bhatia; R Bhatia; M Dhindsa
Journal:  Postgrad Med J       Date:  2004-01       Impact factor: 2.401

View more
  1 in total

1.  Characteristics of urologists predict the use of androgen deprivation therapy for prostate cancer.

Authors:  Vahakn B Shahinian; Yong-fang Kuo; Jean L Freeman; Eduardo Orihuela; James S Goodwin
Journal:  J Clin Oncol       Date:  2007-12-01       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.